| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Apoptosis | 41 | 2022 | 1098 | 3.560 |
Why?
|
| Manduca | 19 | 2020 | 27 | 2.730 |
Why?
|
| Muscular Atrophy | 6 | 2022 | 30 | 2.200 |
Why?
|
| Muscle Fibers, Skeletal | 9 | 2022 | 98 | 1.700 |
Why?
|
| Satellite Cells, Skeletal Muscle | 3 | 2022 | 15 | 1.570 |
Why?
|
| Muscle, Skeletal | 14 | 2022 | 788 | 1.440 |
Why?
|
| Autoantigens | 5 | 2011 | 139 | 1.380 |
Why?
|
| Ribonucleoproteins | 5 | 2011 | 116 | 1.380 |
Why?
|
| Muscles | 15 | 2011 | 179 | 1.340 |
Why?
|
| Cell Death | 11 | 2016 | 289 | 1.310 |
Why?
|
| Gene Expression Regulation | 12 | 2020 | 1630 | 0.820 |
Why?
|
| Cysteine Endopeptidases | 11 | 2002 | 95 | 0.800 |
Why?
|
| Genes, Insect | 6 | 2020 | 98 | 0.780 |
Why?
|
| Myoblasts | 5 | 2013 | 64 | 0.770 |
Why?
|
| Animals | 66 | 2020 | 21345 | 0.710 |
Why?
|
| Cell Nucleus | 6 | 2022 | 630 | 0.700 |
Why?
|
| Neovascularization, Pathologic | 3 | 2017 | 140 | 0.650 |
Why?
|
| Insect Proteins | 8 | 2015 | 83 | 0.620 |
Why?
|
| Moths | 10 | 2008 | 27 | 0.620 |
Why?
|
| Gene Expression Regulation, Developmental | 11 | 2007 | 663 | 0.590 |
Why?
|
| Amino Acid Sequence | 20 | 2020 | 1589 | 0.580 |
Why?
|
| Cytoskeletal Proteins | 3 | 2007 | 204 | 0.580 |
Why?
|
| Ubiquitins | 7 | 2001 | 41 | 0.570 |
Why?
|
| Muscle Development | 8 | 2013 | 60 | 0.560 |
Why?
|
| Carrier Proteins | 4 | 2011 | 718 | 0.520 |
Why?
|
| Molecular Sequence Data | 23 | 2015 | 1979 | 0.520 |
Why?
|
| Metamorphosis, Biological | 8 | 2009 | 33 | 0.510 |
Why?
|
| Transcriptome | 1 | 2020 | 399 | 0.500 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2014 | 278 | 0.500 |
Why?
|
| Multienzyme Complexes | 6 | 2002 | 87 | 0.500 |
Why?
|
| Cell Differentiation | 9 | 2018 | 1386 | 0.490 |
Why?
|
| Models, Theoretical | 2 | 2014 | 274 | 0.470 |
Why?
|
| Drosophila Proteins | 8 | 2011 | 758 | 0.470 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2015 | 15 | 0.470 |
Why?
|
| DNA-Binding Proteins | 5 | 2007 | 1225 | 0.440 |
Why?
|
| Integrins | 3 | 2009 | 109 | 0.410 |
Why?
|
| Glioblastoma | 1 | 2015 | 161 | 0.410 |
Why?
|
| Cell Line | 10 | 2010 | 2024 | 0.390 |
Why?
|
| Lewy Bodies | 2 | 2011 | 3 | 0.390 |
Why?
|
| Testosterone | 1 | 2013 | 128 | 0.380 |
Why?
|
| Base Sequence | 12 | 2020 | 1332 | 0.380 |
Why?
|
| Muscle Contraction | 3 | 2020 | 209 | 0.380 |
Why?
|
| Cloning, Molecular | 7 | 2007 | 385 | 0.370 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 318 | 0.370 |
Why?
|
| Drosophila melanogaster | 2 | 2011 | 559 | 0.340 |
Why?
|
| Muscle Weakness | 1 | 2011 | 33 | 0.340 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2011 | 87 | 0.330 |
Why?
|
| Neuromuscular Junction | 1 | 2011 | 83 | 0.320 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2011 | 226 | 0.320 |
Why?
|
| Sequence Homology, Amino Acid | 9 | 2002 | 364 | 0.320 |
Why?
|
| Motor Neurons | 4 | 2011 | 218 | 0.300 |
Why?
|
| Guanylate Kinases | 1 | 2008 | 8 | 0.290 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2008 | 5 | 0.290 |
Why?
|
| Neurodegenerative Diseases | 1 | 2011 | 152 | 0.290 |
Why?
|
| RNA, Messenger | 10 | 2020 | 1574 | 0.290 |
Why?
|
| Proteasome Endopeptidase Complex | 8 | 2002 | 133 | 0.290 |
Why?
|
| Gene Expression Profiling | 5 | 2020 | 794 | 0.280 |
Why?
|
| Phylogeny | 4 | 2009 | 388 | 0.280 |
Why?
|
| Breast Neoplasms | 2 | 2017 | 1222 | 0.250 |
Why?
|
| T-Lymphocytes | 7 | 1996 | 1008 | 0.240 |
Why?
|
| Transcription Factors | 4 | 1999 | 1556 | 0.240 |
Why?
|
| Transfection | 6 | 2010 | 700 | 0.240 |
Why?
|
| Mice | 15 | 2017 | 11119 | 0.240 |
Why?
|
| Pericytes | 2 | 2018 | 17 | 0.230 |
Why?
|
| LIM Domain Proteins | 5 | 2007 | 32 | 0.220 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 2293 | 0.220 |
Why?
|
| Alternative Splicing | 1 | 2005 | 138 | 0.210 |
Why?
|
| Polymerase Chain Reaction | 4 | 2009 | 513 | 0.210 |
Why?
|
| Immunohistochemistry | 10 | 2010 | 896 | 0.210 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 1997 | 440 | 0.210 |
Why?
|
| Humans | 25 | 2022 | 65140 | 0.200 |
Why?
|
| Gene Expression | 4 | 2016 | 852 | 0.200 |
Why?
|
| Regeneration | 2 | 2016 | 126 | 0.200 |
Why?
|
| Sequence Analysis, DNA | 6 | 2016 | 414 | 0.190 |
Why?
|
| Tumor Cells, Cultured | 2 | 2017 | 426 | 0.190 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 1998 | 449 | 0.190 |
Why?
|
| Ubiquitin | 2 | 2002 | 104 | 0.190 |
Why?
|
| Drosophila | 8 | 2002 | 480 | 0.180 |
Why?
|
| Muscle Proteins | 4 | 2010 | 117 | 0.180 |
Why?
|
| Parkinsonian Disorders | 1 | 2002 | 15 | 0.180 |
Why?
|
| Neurons | 4 | 1996 | 933 | 0.180 |
Why?
|
| Caspases | 4 | 2001 | 176 | 0.180 |
Why?
|
| Nervous System | 5 | 1999 | 71 | 0.180 |
Why?
|
| Cells, Cultured | 8 | 2018 | 2188 | 0.180 |
Why?
|
| Sequence Alignment | 4 | 2008 | 300 | 0.170 |
Why?
|
| Signal Transduction | 7 | 2015 | 3153 | 0.170 |
Why?
|
| Conserved Sequence | 2 | 1999 | 173 | 0.170 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2002 | 129 | 0.170 |
Why?
|
| DNA | 7 | 1996 | 858 | 0.170 |
Why?
|
| Protein Biosynthesis | 2 | 2001 | 333 | 0.170 |
Why?
|
| Actins | 3 | 2001 | 264 | 0.160 |
Why?
|
| RNA Stability | 1 | 2001 | 104 | 0.160 |
Why?
|
| Contractile Proteins | 1 | 2020 | 14 | 0.160 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2001 | 103 | 0.160 |
Why?
|
| Fungal Proteins | 2 | 1998 | 152 | 0.160 |
Why?
|
| Necrosis | 1 | 2001 | 148 | 0.160 |
Why?
|
| Phagocytosis | 2 | 2001 | 257 | 0.160 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2001 | 268 | 0.160 |
Why?
|
| Cell Survival | 3 | 2009 | 587 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 1 | 2002 | 428 | 0.150 |
Why?
|
| Animals, Genetically Modified | 3 | 2011 | 312 | 0.150 |
Why?
|
| Proteins | 3 | 2001 | 764 | 0.150 |
Why?
|
| Genome, Insect | 2 | 2016 | 40 | 0.150 |
Why?
|
| DNA, Complementary | 4 | 2007 | 165 | 0.150 |
Why?
|
| Genes, Reporter | 2 | 2001 | 257 | 0.140 |
Why?
|
| Larva | 3 | 2016 | 158 | 0.140 |
Why?
|
| Hypertrophy | 2 | 2016 | 29 | 0.140 |
Why?
|
| Repressor Proteins | 2 | 1998 | 351 | 0.140 |
Why?
|
| Ganglia, Invertebrate | 3 | 2011 | 5 | 0.140 |
Why?
|
| Thymus Gland | 3 | 1996 | 240 | 0.140 |
Why?
|
| Multigene Family | 2 | 1997 | 106 | 0.140 |
Why?
|
| Neuropeptides | 4 | 2002 | 81 | 0.140 |
Why?
|
| Endopeptidases | 1 | 1998 | 67 | 0.140 |
Why?
|
| Aspartate Carbamoyltransferase | 1 | 1997 | 2 | 0.140 |
Why?
|
| Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing) | 1 | 1997 | 2 | 0.140 |
Why?
|
| Dihydroorotase | 1 | 1997 | 2 | 0.140 |
Why?
|
| Chitinase-3-Like Protein 1 | 1 | 2017 | 14 | 0.130 |
Why?
|
| Peptides | 6 | 2002 | 591 | 0.130 |
Why?
|
| Peptide Hydrolases | 1 | 1998 | 79 | 0.130 |
Why?
|
| Models, Biological | 3 | 2009 | 1192 | 0.130 |
Why?
|
| Lepidoptera | 2 | 1990 | 9 | 0.130 |
Why?
|
| Lysine | 1 | 2017 | 94 | 0.130 |
Why?
|
| Neovascularization, Physiologic | 1 | 2018 | 113 | 0.130 |
Why?
|
| Up-Regulation | 2 | 1996 | 374 | 0.130 |
Why?
|
| Growth | 1 | 1997 | 23 | 0.130 |
Why?
|
| Arginine | 1 | 2017 | 136 | 0.130 |
Why?
|
| Embryonic and Fetal Development | 1 | 1997 | 46 | 0.130 |
Why?
|
| Heparin | 1 | 2017 | 118 | 0.120 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2011 | 500 | 0.120 |
Why?
|
| Cysteine Proteinase Inhibitors | 2 | 1996 | 23 | 0.120 |
Why?
|
| Genes, Regulator | 1 | 1996 | 28 | 0.120 |
Why?
|
| Biopolymers | 1 | 1996 | 72 | 0.120 |
Why?
|
| Protein Isoforms | 2 | 2007 | 201 | 0.120 |
Why?
|
| Ischemia | 1 | 2018 | 203 | 0.120 |
Why?
|
| Stress, Mechanical | 2 | 2009 | 117 | 0.120 |
Why?
|
| Annexin A5 | 2 | 2009 | 20 | 0.110 |
Why?
|
| Aging | 4 | 2011 | 771 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2017 | 203 | 0.110 |
Why?
|
| Alleles | 1 | 1996 | 453 | 0.110 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2015 | 17 | 0.110 |
Why?
|
| Reproductive History | 1 | 2015 | 17 | 0.110 |
Why?
|
| Glass | 2 | 2014 | 23 | 0.110 |
Why?
|
| Flight, Animal | 2 | 2011 | 15 | 0.110 |
Why?
|
| Apolipoproteins | 1 | 1995 | 14 | 0.110 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 1995 | 25 | 0.110 |
Why?
|
| Mice, SCID | 2 | 2017 | 518 | 0.110 |
Why?
|
| Cell Line, Tumor | 2 | 2011 | 1565 | 0.110 |
Why?
|
| Porosity | 1 | 2014 | 41 | 0.110 |
Why?
|
| Metalloendopeptidases | 1 | 1994 | 20 | 0.110 |
Why?
|
| Genetic Variation | 1 | 1996 | 394 | 0.110 |
Why?
|
| Cell Proliferation | 3 | 2017 | 1038 | 0.100 |
Why?
|
| Helminth Proteins | 1 | 1994 | 51 | 0.100 |
Why?
|
| Calcium-Binding Proteins | 1 | 1994 | 94 | 0.100 |
Why?
|
| Blotting, Western | 3 | 2009 | 611 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2020 | 713 | 0.100 |
Why?
|
| Cell Movement | 3 | 2017 | 482 | 0.100 |
Why?
|
| Antigens, CD | 1 | 1995 | 342 | 0.100 |
Why?
|
| Cell Cycle | 1 | 1995 | 398 | 0.100 |
Why?
|
| Cell Separation | 2 | 2009 | 147 | 0.100 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 175 | 0.100 |
Why?
|
| Interferon-gamma | 1 | 1995 | 574 | 0.100 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2013 | 27 | 0.100 |
Why?
|
| Recombinant Proteins | 4 | 1999 | 710 | 0.090 |
Why?
|
| Blotting, Northern | 2 | 2009 | 152 | 0.090 |
Why?
|
| Chromosome Mapping | 2 | 2007 | 296 | 0.090 |
Why?
|
| Genetic Vectors | 3 | 1995 | 918 | 0.090 |
Why?
|
| Myosins | 1 | 1993 | 118 | 0.090 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 308 | 0.090 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1992 | 24 | 0.090 |
Why?
|
| Caenorhabditis elegans | 2 | 1999 | 706 | 0.090 |
Why?
|
| Tissue Distribution | 3 | 2005 | 293 | 0.090 |
Why?
|
| Invertebrates | 1 | 1991 | 19 | 0.090 |
Why?
|
| Female | 8 | 2017 | 34018 | 0.090 |
Why?
|
| Lac Operon | 1 | 2011 | 26 | 0.090 |
Why?
|
| Lewy Body Disease | 1 | 2011 | 15 | 0.090 |
Why?
|
| Nuclear Proteins | 1 | 1996 | 790 | 0.080 |
Why?
|
| Housing, Animal | 1 | 2011 | 15 | 0.080 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 97 | 0.080 |
Why?
|
| Intracellular Space | 1 | 2011 | 33 | 0.080 |
Why?
|
| Vertebrates | 1 | 1991 | 42 | 0.080 |
Why?
|
| RNA | 2 | 1995 | 426 | 0.080 |
Why?
|
| Plastics | 1 | 2011 | 22 | 0.080 |
Why?
|
| Rats | 3 | 2001 | 1994 | 0.080 |
Why?
|
| COS Cells | 1 | 2011 | 180 | 0.080 |
Why?
|
| Caspase 1 | 3 | 1997 | 115 | 0.080 |
Why?
|
| Oxidants | 1 | 2010 | 18 | 0.080 |
Why?
|
| Metallothionein | 1 | 2010 | 8 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 731 | 0.080 |
Why?
|
| Genes | 1 | 1990 | 90 | 0.080 |
Why?
|
| Rabbits | 1 | 2011 | 338 | 0.080 |
Why?
|
| DNA Primers | 2 | 2009 | 301 | 0.080 |
Why?
|
| Neoplasms | 1 | 2001 | 1368 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 287 | 0.080 |
Why?
|
| Transgenes | 1 | 2011 | 204 | 0.080 |
Why?
|
| Caspase 3 | 2 | 2009 | 108 | 0.080 |
Why?
|
| Brain | 2 | 1997 | 1605 | 0.080 |
Why?
|
| Pupa | 2 | 2016 | 18 | 0.080 |
Why?
|
| Polyubiquitin | 2 | 2001 | 9 | 0.080 |
Why?
|
| Transcription, Genetic | 3 | 2005 | 907 | 0.080 |
Why?
|
| Parkinson Disease | 1 | 2011 | 135 | 0.080 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 1994 | 447 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 2 | 2008 | 676 | 0.070 |
Why?
|
| MyoD Protein | 1 | 2009 | 45 | 0.070 |
Why?
|
| Ecdysteroids | 1 | 2009 | 1 | 0.070 |
Why?
|
| Ligases | 2 | 2002 | 27 | 0.070 |
Why?
|
| Cytoskeleton | 1 | 2009 | 141 | 0.070 |
Why?
|
| Simvastatin | 1 | 2009 | 26 | 0.070 |
Why?
|
| HEK293 Cells | 1 | 2011 | 616 | 0.070 |
Why?
|
| Caspase 7 | 1 | 2009 | 17 | 0.070 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2008 | 71 | 0.070 |
Why?
|
| Parvalbumins | 1 | 1988 | 10 | 0.070 |
Why?
|
| Genetic Engineering | 1 | 2009 | 113 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 542 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2010 | 321 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 401 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 583 | 0.070 |
Why?
|
| Organ Specificity | 2 | 1999 | 199 | 0.060 |
Why?
|
| Focal Adhesions | 1 | 2007 | 24 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2011 | 447 | 0.060 |
Why?
|
| Models, Animal | 1 | 2008 | 241 | 0.060 |
Why?
|
| Stem Cells | 1 | 2009 | 276 | 0.060 |
Why?
|
| Chick Embryo | 3 | 1998 | 46 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2009 | 214 | 0.060 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 2 | 1997 | 29 | 0.060 |
Why?
|
| Homeostasis | 1 | 2009 | 379 | 0.060 |
Why?
|
| Ecdysterone | 3 | 1995 | 11 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 1999 | 345 | 0.060 |
Why?
|
| Spinal Cord | 3 | 1998 | 209 | 0.060 |
Why?
|
| Zebrafish | 1 | 2009 | 374 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 3 | 1997 | 868 | 0.060 |
Why?
|
| Transcription Initiation Site | 1 | 2005 | 47 | 0.060 |
Why?
|
| Steroids | 1 | 2005 | 56 | 0.060 |
Why?
|
| Hormones | 1 | 2005 | 62 | 0.060 |
Why?
|
| Adenosine Triphosphatases | 2 | 1998 | 256 | 0.060 |
Why?
|
| Mammary Glands, Animal | 1 | 2005 | 76 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1998 | 111 | 0.050 |
Why?
|
| Genome, Human | 1 | 2007 | 237 | 0.050 |
Why?
|
| Mitochondria | 1 | 2009 | 410 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2011 | 765 | 0.050 |
Why?
|
| Exercise | 1 | 2011 | 964 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 2 | 2015 | 180 | 0.050 |
Why?
|
| Hemocytes | 2 | 2001 | 3 | 0.050 |
Why?
|
| Dactinomycin | 2 | 1994 | 11 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1995 | 185 | 0.050 |
Why?
|
| Gene Library | 2 | 1995 | 102 | 0.050 |
Why?
|
| Synucleins | 1 | 2002 | 2 | 0.050 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2002 | 9 | 0.050 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2002 | 27 | 0.050 |
Why?
|
| Nervous System Physiological Phenomena | 2 | 1997 | 7 | 0.050 |
Why?
|
| Caffeine | 1 | 2002 | 46 | 0.050 |
Why?
|
| Electric Stimulation | 1 | 2002 | 139 | 0.040 |
Why?
|
| Membrane Potentials | 1 | 2002 | 139 | 0.040 |
Why?
|
| Eye Proteins | 1 | 2002 | 73 | 0.040 |
Why?
|
| Cell-Free System | 1 | 2001 | 32 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 1 | 2001 | 108 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 2001 | 48 | 0.040 |
Why?
|
| Half-Life | 1 | 2001 | 81 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2002 | 491 | 0.040 |
Why?
|
| Luciferases | 1 | 2001 | 107 | 0.040 |
Why?
|
| PC12 Cells | 1 | 2001 | 27 | 0.040 |
Why?
|
| 3' Untranslated Regions | 1 | 2001 | 96 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2001 | 47 | 0.040 |
Why?
|
| Keratins | 1 | 2001 | 31 | 0.040 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2001 | 31 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 5614 | 0.040 |
Why?
|
| Histological Techniques | 1 | 2001 | 19 | 0.040 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2001 | 18 | 0.040 |
Why?
|
| Protein Conformation | 2 | 2001 | 792 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2001 | 109 | 0.040 |
Why?
|
| Mutation | 3 | 2018 | 2661 | 0.040 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 2 | 2002 | 24 | 0.040 |
Why?
|
| Epitopes | 1 | 2001 | 291 | 0.040 |
Why?
|
| Abdomen | 2 | 1994 | 94 | 0.040 |
Why?
|
| Male | 4 | 2018 | 31047 | 0.040 |
Why?
|
| Zinc Fingers | 1 | 1999 | 105 | 0.040 |
Why?
|
| Enzyme Precursors | 1 | 1998 | 11 | 0.040 |
Why?
|
| Nerve Growth Factors | 1 | 1998 | 28 | 0.030 |
Why?
|
| Receptors, Leptin | 1 | 2018 | 15 | 0.030 |
Why?
|
| Collateral Circulation | 1 | 2018 | 28 | 0.030 |
Why?
|
| Adult | 2 | 2015 | 17358 | 0.030 |
Why?
|
| Mammals | 1 | 1999 | 222 | 0.030 |
Why?
|
| Vascular Remodeling | 1 | 2018 | 23 | 0.030 |
Why?
|
| Phenotype | 2 | 2018 | 1233 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 2018 | 116 | 0.030 |
Why?
|
| RNA Polymerase II | 1 | 1997 | 86 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 1997 | 213 | 0.030 |
Why?
|
| Macrophages | 2 | 2001 | 1038 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2018 | 301 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 1999 | 350 | 0.030 |
Why?
|
| Synteny | 1 | 2016 | 24 | 0.030 |
Why?
|
| Inhibitor of Apoptosis Proteins | 3 | 2002 | 40 | 0.030 |
Why?
|
| Cytoplasm | 2 | 1996 | 283 | 0.030 |
Why?
|
| Amyloid beta-Peptides | 1 | 1998 | 321 | 0.030 |
Why?
|
| Genomic Library | 1 | 1996 | 10 | 0.030 |
Why?
|
| Hot Temperature | 1 | 1996 | 145 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 1996 | 67 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 1997 | 144 | 0.030 |
Why?
|
| Tissue Extracts | 1 | 1995 | 11 | 0.030 |
Why?
|
| Toes | 1 | 1995 | 14 | 0.030 |
Why?
|
| DNA, Antisense | 1 | 1995 | 17 | 0.030 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 1995 | 19 | 0.030 |
Why?
|
| Nephropidae | 1 | 1995 | 2 | 0.030 |
Why?
|
| Binding Sites | 1 | 2017 | 921 | 0.030 |
Why?
|
| Povidone | 1 | 1995 | 8 | 0.030 |
Why?
|
| Antigens, CD20 | 1 | 1995 | 13 | 0.030 |
Why?
|
| Replication Origin | 1 | 1995 | 36 | 0.030 |
Why?
|
| Morphogenesis | 1 | 1995 | 120 | 0.030 |
Why?
|
| Subtraction Technique | 1 | 1995 | 24 | 0.030 |
Why?
|
| Hybridomas | 1 | 1995 | 63 | 0.030 |
Why?
|
| Hydrolysis | 1 | 1995 | 147 | 0.030 |
Why?
|
| Isoenzymes | 1 | 1995 | 130 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2001 | 919 | 0.030 |
Why?
|
| Diffusion | 1 | 2014 | 82 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2015 | 67 | 0.030 |
Why?
|
| Antigens, Viral | 1 | 1995 | 130 | 0.030 |
Why?
|
| Ganglia, Sympathetic | 1 | 1994 | 5 | 0.030 |
Why?
|
| Silicon Dioxide | 1 | 1995 | 63 | 0.030 |
Why?
|
| Chickens | 1 | 1994 | 94 | 0.030 |
Why?
|
| Genes, Helminth | 1 | 1994 | 58 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 1995 | 355 | 0.030 |
Why?
|
| Insulin | 1 | 2018 | 695 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 1994 | 104 | 0.030 |
Why?
|
| HeLa Cells | 1 | 1995 | 541 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 1994 | 152 | 0.020 |
Why?
|
| Herpesvirus 4, Human | 1 | 1995 | 199 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 1994 | 127 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1998 | 570 | 0.020 |
Why?
|
| Trans-Activators | 1 | 1995 | 321 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1995 | 153 | 0.020 |
Why?
|
| Nerve Net | 1 | 1994 | 100 | 0.020 |
Why?
|
| Biological Evolution | 1 | 1994 | 128 | 0.020 |
Why?
|
| Protein Binding | 1 | 2017 | 1640 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 740 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 1995 | 663 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2013 | 104 | 0.020 |
Why?
|
| Central Nervous System | 3 | 2001 | 200 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1994 | 341 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2014 | 483 | 0.020 |
Why?
|
| Transformation, Bacterial | 1 | 1992 | 12 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1994 | 281 | 0.020 |
Why?
|
| Chromosomes | 1 | 1993 | 139 | 0.020 |
Why?
|
| Plasmids | 1 | 1992 | 294 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 1990 | 56 | 0.020 |
Why?
|
| DNA Damage | 1 | 1993 | 297 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1990 | 37 | 0.020 |
Why?
|
| Serum | 1 | 2010 | 27 | 0.020 |
Why?
|
| Wings, Animal | 2 | 1996 | 28 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 3485 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 1990 | 71 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 203 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 1990 | 197 | 0.020 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2009 | 9 | 0.020 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2009 | 8 | 0.020 |
Why?
|
| Biomarkers | 1 | 1995 | 1480 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2015 | 827 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2009 | 64 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2015 | 2620 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 1988 | 71 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1988 | 233 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2015 | 3308 | 0.020 |
Why?
|
| RNA Interference | 1 | 2010 | 643 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1992 | 714 | 0.020 |
Why?
|
| Neuroglia | 2 | 1997 | 81 | 0.010 |
Why?
|
| Substrate Specificity | 2 | 1998 | 341 | 0.010 |
Why?
|
| Hemolymph | 1 | 1983 | 3 | 0.010 |
Why?
|
| Pigmentation | 1 | 1983 | 25 | 0.010 |
Why?
|
| Time Factors | 1 | 2010 | 3762 | 0.010 |
Why?
|
| United States | 1 | 2015 | 8093 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2001 | 56 | 0.010 |
Why?
|
| Photoreceptor Cells, Invertebrate | 1 | 2001 | 38 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2001 | 156 | 0.010 |
Why?
|
| Lipoproteins | 1 | 2001 | 85 | 0.010 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2001 | 127 | 0.010 |
Why?
|
| Age Factors | 1 | 1983 | 1586 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1998 | 111 | 0.010 |
Why?
|
| Eye | 1 | 1998 | 59 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 18273 | 0.010 |
Why?
|
| Peptide Biosynthesis | 1 | 1997 | 10 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1997 | 116 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1997 | 84 | 0.010 |
Why?
|
| DNA Ligases | 1 | 1996 | 3 | 0.010 |
Why?
|
| Leupeptins | 1 | 1996 | 16 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 1997 | 184 | 0.010 |
Why?
|
| Acetylcysteine | 1 | 1996 | 25 | 0.010 |
Why?
|
| Neurosecretory Systems | 1 | 1996 | 24 | 0.010 |
Why?
|
| Immunochemistry | 1 | 1995 | 9 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1996 | 213 | 0.010 |
Why?
|
| Axons | 1 | 1995 | 124 | 0.010 |
Why?
|
| Oligopeptides | 1 | 1995 | 135 | 0.010 |
Why?
|
| Species Specificity | 1 | 1995 | 339 | 0.010 |
Why?
|
| Cattle | 1 | 1995 | 320 | 0.010 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 1994 | 13 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1994 | 19 | 0.010 |
Why?
|
| Receptors, Steroid | 1 | 1994 | 29 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1994 | 103 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 1994 | 151 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1995 | 875 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 1994 | 1290 | 0.000 |
Why?
|
| Pregnancy | 1 | 1995 | 2372 | 0.000 |
Why?
|